|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 9/00 | |
| A61K 31/519 |
| (11) | Number of the document | 2344124 |
| (13) | Kind of document | T |
| (96) | European patent application number | 09737241.1 |
| Date of filing the European patent application | 2009-09-29 | |
| (97) | Date of publication of the European application | 2011-07-20 |
| (45) | Date of publication and mention of the grant of the patent | 2017-02-22 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2009/058810 |
| Date | 2009-09-29 |
| (87) | Number | WO 2010/039722 |
| Date | 2010-04-08 |
| (30) | Number | Date | Country code |
| 101548 P | 2008-09-30 | US | |
| 117448 P | 2008-11-24 | US |
| (72) |
KUZMA, Petr, US
QUANDT, Harry, US
|
| (73) |
Braeburn Pharmaceuticals, Inc.,
47 Hulfish Street, Princeton, NJ 08542,
US
|
| (54) | IMPLANTABLE DEVICE FOR THE DELIVERY OF RISPERIDONE AND METHODS OF USE THEREOF |
| IMPLANTABLE DEVICE FOR THE DELIVERY OF RISPERIDONE AND METHODS OF USE THEREOF |